
### [NCIT:C8334](http://purl.obolibrary.org/obo/NCIT_C8334)
**Label:** Squamous Cell Intraepithelial Neoplasia

**Subclasses:** [NCIT:C7667](http://purl.obolibrary.org/obo/NCIT_C7667) (High Grade Penile Intraepithelial Neoplasia), [NCIT:C7666](http://purl.obolibrary.org/obo/NCIT_C7666) (Low Grade Penile Intraepithelial Neoplasia), [NCIT:C7347](http://purl.obolibrary.org/obo/NCIT_C7347) (Cervical Squamous Cell Carcinoma In Situ), [NCIT:C27790](http://purl.obolibrary.org/obo/NCIT_C27790) (Penile Carcinoma In Situ), [NCIT:C7669](http://purl.obolibrary.org/obo/NCIT_C7669) (High Grade Corneal Intraepithelial Neoplasia), [NCIT:C7668](http://purl.obolibrary.org/obo/NCIT_C7668) (High Grade Conjunctival Intraepithelial Neoplasia), [NCIT:C8335](http://purl.obolibrary.org/obo/NCIT_C8335) (Low Grade Squamous Intraepithelial Neoplasia), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C8336](http://purl.obolibrary.org/obo/NCIT_C8336) (High Grade Squamous Intraepithelial Neoplasia), [NCIT:C7346](http://purl.obolibrary.org/obo/NCIT_C7346) (Cervical Squamous Intraepithelial Neoplasia), [NCIT:C7665](http://purl.obolibrary.org/obo/NCIT_C7665) (Grade II Penile Intraepithelial Neoplasia), [NCIT:C4596](http://purl.obolibrary.org/obo/NCIT_C4596) (Penile Intraepithelial Neoplasia), [NCIT:C6097](http://purl.obolibrary.org/obo/NCIT_C6097) (Low Grade Conjunctival Intraepithelial Neoplasia), [NCIT:C6052](http://purl.obolibrary.org/obo/NCIT_C6052) (Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C136719](http://purl.obolibrary.org/obo/NCIT_C136719) (Squamous Cell Lung Carcinoma In Situ), [NCIT:C28292](http://purl.obolibrary.org/obo/NCIT_C28292) (Squamous Cell Carcinoma In Situ of the Nipple), [NCIT:C133255](http://purl.obolibrary.org/obo/NCIT_C133255) (Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8), [NCIT:C27423](http://purl.obolibrary.org/obo/NCIT_C27423) (Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C8903](http://purl.obolibrary.org/obo/NCIT_C8903) (Stage 0 Bladder Squamous Cell Carcinoma), [NCIT:C8763](http://purl.obolibrary.org/obo/NCIT_C8763) (Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7), [NCIT:C7351](http://purl.obolibrary.org/obo/NCIT_C7351) (Grade II Squamous Intraepithelial Neoplasia), [NCIT:C27427](http://purl.obolibrary.org/obo/NCIT_C27427) (Low Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C6121](http://purl.obolibrary.org/obo/NCIT_C6121) (Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C27426](http://purl.obolibrary.org/obo/NCIT_C27426) (High Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C6120](http://purl.obolibrary.org/obo/NCIT_C6120) (Conjunctival Intraepithelial Neoplasia), [NCIT:C6093](http://purl.obolibrary.org/obo/NCIT_C6093) (Corneal Intraepithelial Neoplasia), [NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1), [NCIT:C6094](http://purl.obolibrary.org/obo/NCIT_C6094) (Low Grade Corneal Intraepithelial Neoplasia), [NCIT:C40197](http://purl.obolibrary.org/obo/NCIT_C40197) (High Grade Cervical Squamous Intraepithelial Neoplasia), [NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2), [NCIT:C40196](http://purl.obolibrary.org/obo/NCIT_C40196) (Low Grade Cervical Squamous Intraepithelial Neoplasia), [NCIT:C3639](http://purl.obolibrary.org/obo/NCIT_C3639) (Tracheal Carcinoma In Situ), [NCIT:C27093](http://purl.obolibrary.org/obo/NCIT_C27093) (Stage 0 Squamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C32542](http://purl.obolibrary.org/obo/NCIT_C32542) (Esophageal Squamous Cell))) 53.85%
- Thing 52.89%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C3958](http://purl.obolibrary.org/obo/NCIT_C3958) (Disseminated Peritoneal Leiomyomatosis))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39573](http://purl.obolibrary.org/obo/NCIT_C39573) (T-Lymphocyte with a Post-Thymic Immunophenotype))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39572](http://purl.obolibrary.org/obo/NCIT_C39572) (Neoplastic Cerebriform T-Prolymphocyte))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39571](http://purl.obolibrary.org/obo/NCIT_C39571) (Neoplastic Small T-Prolymphocyte))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39569](http://purl.obolibrary.org/obo/NCIT_C39569) (Cytoplasmic Protrusions Present))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39565](http://purl.obolibrary.org/obo/NCIT_C39565) (Coarse Azurophilic Granules Present))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C3939](http://purl.obolibrary.org/obo/NCIT_C3939) (Bannayan Syndrome))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39301](http://purl.obolibrary.org/obo/NCIT_C39301) (CD4+/CD56+ Neoplastic Medium-Sized Cell))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39300](http://purl.obolibrary.org/obo/NCIT_C39300) (Precursor Natural Killer Cell))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39294](http://purl.obolibrary.org/obo/NCIT_C39294) (Schistosoma Hematobium Infection))) 39.20%
- [NCIT:C12849](http://purl.obolibrary.org/obo/NCIT_C12849) (Squamous Cell) and (not ([NCIT:C39293](http://purl.obolibrary.org/obo/NCIT_C39293) (Helicobacter Pylori Infection))) 39.20%


